Measuring virtual care impact with closed claims from HealthVerity Marketplace
Digital health innovators and pharma leaders are under increasing pressure to show that new models...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists...
Digital health innovators and pharma leaders are under increasing pressure to show that new models...
Recently, Omada Health and HealthVerity announced a press release highlighting their collaboration...
(Part 2) In Part 1 we explored how HealthVerity Marketplace delivers high-quality,...
Few areas of medicine have captured public interest over the past two years quite like...
Understanding disparities in opioid use disorder (OUD) treatment Pharmaceutical companies committed...
(Part 1) When clients see real-world data (RWD) in HealthVerity Marketplace, it may appear...
Electronic Health Records (EHR): What they are and how to use them in real-world data Electronic...
Antiretroviral therapy (ART) has transformed outcomes for people living with HIV, especially those...
In this edition of our Ask an Expert series, we turn to Emery Niemiec, Senior Director,...
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that gradually erodes memory and cognitive function, affecting patients and their families long before the disease reaches its final stages.¹ As the population...